Insulet (PODD) Stock Buyback History
TTM buyback yield 0.30% · Shareholder yield (TTM) 0.30%.
Insulet
PODD
TTM buyback yield
0.30%
Shareholder yield (TTM)
0.30%
5Y share count change
9.0%
TTM buyback spend
$59.60M
SBC coverage (TTM)
1.41x
Diluted vs basic shares (annual)
Weighted average shares from the income statement: diluted (EPS denominator and typical buyback-yield basis) compared with basic.
Shares outstanding (annual)
Year-over-year change in diluted weighted average shares (industry-standard for EPS and per-share capital return). Green is fewer shares vs the prior fiscal year; red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield
Buybacks vs stock-based compensation
TTM coverage: 1.41x (buybacks ÷ SBC). Bars are fiscal-year totals.
Buyback spending history
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $59.60M | $62.70M | −$3.10M | 0.07B | -2.7% | 0.30% |
| 2024 | $0.00 | $69.30M | −$69.30M | 0.07B | 0.3% | — |
| 2023 | $0.00 | $48.30M | −$48.30M | 0.07B | 5.3% | — |
| 2022 | $0.00 | $40.90M | −$40.90M | 0.07B | 1.9% | — |
| 2021 | $0.00 | $34.40M | −$34.40M | 0.07B | 4.0% | — |
| 2020 | $0.00 | $35.90M | −$35.90M | 0.07B | 5.8% | — |
| 2019 | $0.00 | $28.70M | −$28.70M | 0.06B | 2.1% | — |
| 2018 | $0.00 | $37.50M | −$37.50M | 0.06B | 5.2% | — |
| 2017 | $0.00 | $31.90M | −$31.90M | 0.06B | 1.3% | — |
| 2016 | $0.00 | $23.62M | −$23.62M | 0.06B | 0.8% | — |
| 2015 | $0.00 | $19.18M | −$19.18M | 0.06B | 2.1% | — |
| 2014 | $0.00 | $22.52M | −$22.52M | 0.06B | 3.0% | — |
| 2013 | $0.00 | $12.68M | −$12.68M | 0.05B | 12.7% | — |
| 2012 | $0.00 | $9.92M | −$9.92M | 0.05B | 2.6% | — |
| 2011 | $0.00 | $7.73M | −$7.73M | 0.05B | 17.9% | — |
| 2010 | $0.00 | $5.06M | −$5.06M | 0.04B | 33.2% | — |
| 2009 | $0.00 | $4.20M | −$4.20M | 0.03B | 7.7% | — |
| 2008 | $0.00 | $3.37M | −$3.37M | 0.03B | 65.5% | — |
| 2007 | $0.00 | $0.00 | $0.00 | 0.02B | 1719.3% | — |
| 2006 | $0.00 | $0.00 | $0.00 | 0.00B | 200.8% | — |
| 2005 | $0.00 | $0.00 | $0.00 | 0.00B | 5.1% | — |
| 2004 | $0.00 | $0.00 | $0.00 | 0.00B | — | — |
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
TTM buybacks vs headroom (FCF − dividends, TTM)16% of headroom
Headroom $377.70M (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Does Insulet buy back its own stock?
- Yes, Insulet (PODD) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Insulet spend on share buybacks?
- Trailing twelve months (TTM) buyback spend is about $59.60M (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Insulet's buyback yield?
- TTM buyback yield is about 0.30% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Insulet's shareholder yield?
- Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 0.30% combined (TTM-based where available).
Is Insulet diluting shareholders?
- Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Insulet's share count changed?
- Diluted weighted average shares changed by about 9.0% over roughly five fiscal years (annual income statement data).